SAN DIEGO – Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the acceptance for publication of the manuscript titled, “Fetal RHD Genotype Detection from Circulating Cell-Free Fetal DNA in Maternal Plasma in Non-Sensitized RhD Negative Women.” The article is currently available online and will appear in the next […]
WOBURN, Mass. – Avantra® Biosciences, a leading innovator in protein diagnostics, announces a Rapid Assay Prototyping Service. Avantra’s new service allows researchers to cost effectively accelerate their research efforts using custom designed biomarker assays developed on Avantra’s proven QPDx™ BioChip platform. The QPDx™ platform offers users rapid, easy-to-use, quantitative multiplex protein assays using catalog or […]
SALT LAKE CITY – This week the U.S. Food and Drug Administration cleared the first nucleic acid amplification In vitro diagnostic (IVD) test that detects Coxiella burnetii, the bacteria that causes Q fever. The test developed by Idaho Technology, Inc. (ITI) will be used to test military personnel suspected of contracting the disease and run […]
SANTA ANA, Calif. – AquaStar Holdings, Inc. (Pink Sheets: RPPR) is pleased to announce that the Company’s wholly-owned subsidiary, SUTIMCo, Inc., has retained the services of Mr. Ed Ellsworth as Vice President of Business Development. Mr. Ellsworth will assist with the development and positioning of the numerous University conceived technologies that SUTIMCo manages. Mr. Ellsworth, […]
AUSTIN, Texas – Asuragen, Inc., a leader in the development of molecular diagnostics, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (“USPTO”) for claims related to the use of miRNAs as normalizers in gene expression studies. Data normalization is necessary to control for sample variability […]
FREDERICK, Md. – Akonni Biosystems, Inc., today announced that it has appointed Jan Smilek as its Chief Financial Officer, effective immediately. Akonni, founded in 2003, is developing and commercializing novel nucleic acid extraction and microarray-based testing systems designed to rapidly and economically analyze biological samples. These systems will be used in clinical laboratory and research […]
Ithaca, NY – Rheonix, Inc., developer of the Rheonix CARD® system that provides a powerful microfluidic platform for the evolving molecular diagnostics industry, announced that on June 14, 2011 the U.S. Patent and Trademark Office will issue Patent Number 7,959,875, “Microfluidic Chips and Assay Systems? and on April 13, 2011 it allowed Patent Application Number […]
Ann Arbor, MI and London, UK – NextGen Group plc (AIM:NGG) is pleased to announce that its subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched the first phase of its multiple protein (multiplex) assays in plasma, for CNS diseases. The plasmamultiplesclerosis15 assay simultaneously measures 15 human plasma proteins that […]
ORLANDO, Fla. – GeneLink Biosciences, Inc. (OTCBB: GNLK.OB, “the Company,” “GeneLink,” or “GeneLink Biosciences”), a leading consumer genomics biotech company, held its Scientific Advisory Board Meeting at Disney’s Contemporary Resort Convention Center in Orlando, Florida from May 20-22, 2011. GeneLink Biosciences hosted the three day meeting to focus on the Company’s growth strategy and the […]
Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) today signed a major OEM agreement with a global leader in a fast growing field of diagnostics for the development and supply of a dedicated diagnostics instrument. Under the agreement, Tecan will develop and supply an instrument to be used in conjunction with diagnostic tests […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
